Envestnet Portfolio Solutions
RXST icon

Envestnet Portfolio Solutions’s RxSight RXST Stock Holding History

Envestnet Portfolio Solutions’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-76,959
Closed -$3.8M – 1789
2024
Q3 		$3.8M Buy
+76,959
New +$3.94M 0.01% 464

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Envestnet Portfolio Solutions's RXST Position: Q4 2024 in Review

Envestnet Portfolio Solutions sold out of RxSight (RXST) in Q4 2024, closing a stake of 76,959 shares — an estimated $3.8M sold.

Envestnet Portfolio Solutions first reported a position in RXST in Q3 2024 and held it in 1 quarter. The position peaked at $3.8M in Q3 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Envestnet Portfolio Solutions reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 76,959 RxSight shares in Q4 2024, an estimated $3.8M.
  • Envestnet Portfolio Solutions first reported a position in RxSight in Q3 2024 and held it in 1 quarter.
  • Envestnet Portfolio Solutions's RxSight position peaked at $3.8M in Q3 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Envestnet Portfolio Solutions's 13F filing for Q4 2024, filed 10 Feb 2025.